Legacy Education (LGCY) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Mar, 2026Executive summary
Revenue grew 40.7% year-over-year to $19.2 million in Q2, driven by a 49.4% rise in new student starts and a 16.8% increase in enrollment, marking the fourteenth consecutive quarter of double-digit revenue growth.
Net income rose 46% to $2.0 million in Q2, with diluted EPS up 50% to $0.15; adjusted EBITDA increased 61.6% to $3.0 million.
For the six months ended December 31, 2025, revenue grew 39.6% to $38.6 million, net income increased 21.2% to $4.2 million, and adjusted EBITDA rose 30.3% to $6.1 million.
The company operates four accredited institutions in California, with a total student population of 3,234 as of December 31, 2025.
Strong enrollment growth, program expansion, and disciplined cost management drove results.
Financial highlights
Q2 revenue: $19.2 million (up from $13.6 million year-over-year); six-month revenue: $38.6 million (up from $27.6 million year-over-year).
Q2 adjusted EBITDA: $3.3 million, up 61.6%; six-month adjusted EBITDA: $6.1 million, up 30.3%.
Q2 net income: $2.0 million (up from $1.4 million); six-month net income: $4.2 million (up from $3.5 million).
Diluted EPS: $0.15 in Q2 (up from $0.10); $0.30 for six months (up from $0.29).
Cash and cash equivalents at quarter end: $21.1 million; working capital: $27 million; total assets: $73.1 million; total stockholders' equity: $46.1 million; debt: $600,000.
Outlook and guidance
Management expects continued growth as demand for healthcare programs accelerates and the platform scales.
Continued focus on enrollment growth, digital marketing optimization, and expanding referral channels.
Full deployment of four new allied health programs and pursuit of additional regulatory approvals.
Measured approach to growth, including accretive acquisitions and organic expansion.
Confident in announcing at least one acquisition before fiscal year-end.
Latest events from Legacy Education
- Achieved 42% revenue growth and 17% enrollment growth, with strong student outcomes and robust liquidity.LGCY
Investor presentation20 Mar 2026 - Achieved 40% revenue growth and 38% enrollment increase, driven by healthcare-focused programs and acquisitions.LGCY
Investor presentation12 Feb 2026 - Revenue up 35%, net income doubled, and expansion fueled by IPO and $8M acquisition.LGCY
Q1 202514 Jan 2026 - Q2 FY2025 revenue up 29.2% with record enrollment and expanded healthcare offerings.LGCY
Q2 202516 Dec 2025 - Virtual meeting to elect six directors, ratify auditor, and review governance and compensation.LGCY
Proxy Filing2 Dec 2025 - Annual proxy details voting items and confirms standard shareholder rights.LGCY
Proxy Filing2 Dec 2025 - IPO targets $10.28M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025 - IPO seeks $10.28M to fund growth, with strong financials but high regulatory exposure.LGCY
Registration Filing29 Nov 2025 - IPO seeks up to $11.95M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025